Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Int J Cardiol. 2013 Jul 15;167(1):63-6. doi: 10.1016/j.ijcard.2011.11.082. Epub 2011 Dec 20.

    Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries.

    Source

    Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. Electronic address: otutarel@hotmail.com.

    Abstract

    BACKGROUND:

    Recently, the microRNA miR-423_5p was identified as a biomarker for left ventricular heart failure. Its role in patients with a systemic right ventricle and reduced ejection fraction after atrial repair for transposition of the great arteries has not been evaluated.

    METHODS:

    In 41 patients and 10 age- and sex-matched healthy controls circulating miR-423_5p concentration was measured and correlated to clinical parameters, cardiac functional parameters assessed by magnetic resonance imaging, and cardiopulmonary exercise testing.

    RESULTS:

    Levels of circulating miR-423_5p showed no difference between patients and controls. Further, there was no correlation between miR-423_5p and parameters of cardiopulmonary exercise testing or imaging findings.

    CONCLUSIONS:

    In patients with a systemic right ventricle and reduced ejection fraction miR-423_5p levels are not elevated. Therefore, circulating miR-423_5p is not a useful biomarker for heart failure in this patient group.

    Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

    PMID:
    22188991
    [PubMed - in process]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk